Subcutaneous model revealed that tumor growth was significantly increased in mice co-injected with CC cells and NFs pre-treated by SiHa-Wnt2B/Hela-Wnt2B/ME180-Wnt2B compared with SiHa-NC/Hela-NC/ME180-NC pre-treated groups or the control groups. The gene discussed is WNT2B; the disease is neoplasm.